Results were announced from a phase 3 study evaluating an investigational intramuscular (IM) formulation of ibalizumab-uiyk for the treatment of heavily treatment-experienced adults with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback